Serous carcinoma. The patient performed other staging exams (breast ultrasound and mammography) which were suspicious for carcinomatous other staging exams (breast ultrasound and mammography) which had been suspicious for carcinomatous lymphangitis. Biopsy of breast skin lesion revealed the presence of carcinomatous lymphangitis lymphangitis. Biopsy of your the breast skin lesion revealed the presence of carcinomatous lymphangitis (D), whereas immunohistochemistrynegativitynegativity for CK20, GATA3 (E) andfor CK7 (D), whereas immunohistochemistry showed showed for CK20, GATA3 (E) and positivity positivity for CK7 (F), PAX8 and WT1. The immunochemistry pattern demonstrated the ovarian origin (F), PAX8 and WT1. The immunochemistry pattern demonstrated the ovarian origin of breast lesions. Just after the diagnosis of metastatic disease, the patient underwent chemotherapy with carboplatin andwww.mdpi/journal/diagnosticsmdpi/journal/diagnosticsDiagnostics 2021, 11, 2106. 10.3390/diagnosticsDiagnostics 2021, 11, 2106. 10.3390/diagnosticsDiagnostics 2021, 11,two ofpaclitaxel with partial radiological response soon after three cycles. As a result of inoperable disease, the patient continued chemotherapy with the addition of bevacizumab, acquiring partial remedy response at final follow-up (about one year after the diagnosis of carcinomatous lymphangitis). Carcinomatous lymphangitis may be a metastatic manifestation of different tumors; the most prevalent principal web-sites are breast, lung and stomach, whereas in rare situations it may be as a consequence of ovarian cancer . In the described case, an integrated diagnostic approach was pretty helpful to detect breast carcinomatous lymphangitis as an uncommon presentation of metastatic ovarian cancer. Author Contributions: Conceptualization, B.M. and M.D.G.; investigation, B.M., P.M. and M.D.G.; information curation, B.M., P.M. and M.D.G.; writing–original draft preparation, B.M. and G.T.; writing– assessment and editing, M.D.G. and G.T. All authors have read and agreed to the BS3 Crosslinker Antibody-drug Conjugate/ADC Related Published version of your manuscript. Funding: This study received no external funding. Institutional Review Board Statement: Not applicable. Informed Consent Statement: Written informed consent was obtained in the patient to publish this paper. Data Availability Statement: Original data supporting the reported results are available contacting the authors. Conflicts of Interest: The authors declare no conflict of interest.ArticleThe Behavioural Outcomes of Young children with Autism Spectrum Disorder along with other Developmental Disabilities as Perceived by Parents during the COVID-19 LockdownKathleen Franz 1 and Michelle E. Kelly two, 1School of Psychology, Trinity College Dublin, Dublin two, Ireland; [email protected] Department of Psychology, National College of Ireland, Mayor Street Reduced, IFSC, Dublin 1, Ireland Correspondence: [email protected]: Franz, K.; Kelly, M.E. The Behavioural Outcomes of Children with Autism Spectrum Disorder and also other Developmental Disabilities as Perceived by Parents through the COVID-19 Lockdown. Disabilities 2021, 1, 34760. 10.3390/disabilities1040024 Academic Editors: Janet Finlayson and Stuart Todd Received: 31 August 2021 Accepted: 6 October 2021 Published: 12 OctoberAbstract: The COVID-19 lockdown and closure of schools, clinics, and community-based services place kids with autism spectrum disorders (ASDs) along with other developmental disabilities (DDs) at increased danger of damaging outcomes. This study aimed to investigate parents’ perceptions.